Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious

🗓️ May 13, 2025 | WSJ Summary by EverHealth AI


📘 Summary:

The U.S. and China agreed to de-escalate trade tensions, reducing tariffs on Chinese goods from 125% to 10% for 90 days. This news led to a major stock rally, with the Dow Jones surging over 1,100 points and the Nasdaq entering a bull market. However, investors remain cautious due to the temporary nature of the tariff reduction and ongoing trade uncertainties.


📈 Market Reaction: Strong Rally Amid Caution

  • Dow Jones jumped 1,100 points (+2.8%), Nasdaq entered a bull market (+4.3%), and S&P 500 gained 3.3%.

  • Tech stocks like Amazon (+8.1%) and Nike (+7.3%) led the surge.

  • Investors shifted back to growth stocks after a volatile April.


🌐 U.S.-China Trade Truce: Temporary Relief

  • The U.S. reduced tariffs on Chinese goods to 10% from 125% for 90 days, with a separate 20% tariff still in effect.

  • The 90-day reduction is temporary and may be reversed if trade talks fail.

  • Companies like Tesla, Apple, and other exporters surged on the news.


💡 Investor Sentiment: Mixed Outlook

  • Many analysts warn that the 90-day window is only a delay, not a resolution.

  • Goldman Sachs reduced the odds of a U.S. recession from 45% to 35%.

  • Uncertainty remains as businesses continue to face supply chain disruptions.


📊 Broader Implications: Rebound and Risk

  • The Magnificent Seven tech firms gained a collective $830.9 billion in market value.

  • The dollar rose, bond yields climbed, and Fed rate cuts are now seen as less likely.

  • Analysts highlight that future trade negotiations are crucial for sustained recovery.


✅ Key Takeaway:

The U.S.-China trade thaw triggered a major market rally, but the temporary nature of the tariff reduction leaves uncertainty high. Investors are cautious as they await further trade developments.

Sources & Methodology: Market data sourced from TradingView, Finviz, FRED, and SEC EDGAR filings. All analysis and commentary represent the author's independent assessment and is intended for educational purposes only.
Written & reviewed by Luke, Independent Market Analyst
EverHealthAI

Luke — Independent Market Analyst

Luke is an independent market analyst and the founder of EverHealthAI. He covers U.S. equities, geopolitical risk, macroeconomic trends, and AI infrastructure — with a focus on helping long-term investors understand the forces shaping capital markets. All content is written and edited by a human author and is intended for educational purposes only. Learn more →

Scroll to Top